While the number and proportion of most CD4+ cTfh subsets were remarkably similar between HC and both patients groups, a significantly smaller Tfh1 cell population was observed in RA-MTX and MS-OCR patients as compared to HC before vaccination (Figure 3—figure supplement 1a, b). Here, CD4 is linked to myeloid sarcoma.